Evidence map›Paper›PMID 41160492›Full record

ArticleBioinformatics (Oxford, England)2025

DARKIN: a zero-shot benchmark for phosphosite-dark kinase association using protein language models.

Emine Ayşe Sunar, Zeynep Işık, Mert Pekey, Ramazan Gökberk Cinbiş, Oznur Tastan

Abstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Emine Ayşe SunarFaculty of Engineering and Natural Sciences, Sabanci University, Istanbul 34956, Türkiye.
Zeynep IşıkFaculty of Engineering and Natural Sciences, Sabanci University, Istanbul 34956, Türkiye.
Mert PekeyFaculty of Engineering and Natural Sciences, Sabanci University, Istanbul 34956, Türkiye.
Ramazan Gökberk CinbişDepartment of Computer Engineering, Middle East Technical University, Ankara 06800, Türkiye.
Oznur TastanFaculty of Engineering and Natural Sciences, Sabanci University, Istanbul 34956, Türkiye.ORCID 0000-0001-7058-5372

Funding

Scientific and Technological Research Council of Turkey
6 · The paper itself

Abstract

motivationProtein language models (pLMs) have emerged as powerful tools for capturing the intricate information encoded in protein sequences, facilitating various downstream protein prediction tasks. With numerous pLMs available, there is a critical need for diverse benchmarks to systematically evaluate their performance across biologically relevant tasks. Here, we introduce DARKIN, a zero-shot classification benchmark designed to assign phosphosites to understudied kinases, termed dark kinases. Kinases, which catalyze phosphorylation, are central to cellular signaling pathways. While phosphoproteomics enables the large-scale identification of phosphosites, determining the cognate kinase responsible for the phosphorylation event remains an experimental challenge.

resultsIn DARKIN, we prepared training, validation, and test folds that respect the zero-shot nature of this classification problem, incorporating stratification based on kinase groups and sequence similarity. We evaluated multiple pLMs using two zero-shot classifiers: a novel, training-free k-NN-based method, and a bilinear classifier. Our findings indicate that ESM, ProtT5-XL, and SaProt exhibit superior performance on this task. DARKIN provides a challenging benchmark for assessing pLM efficacy and fosters deeper exploration of under-characterized (dark) kinases by offering a biologically relevant test bed. AVAILABILITY AND IMPLEMENTATION: The DARKIN benchmark data and the scripts for generating additional splits are publicly available at: https://github.com/tastanlab/darkin.

Indexed as

Computational BiologyPhosphoproteinsProtein KinasesSoftwareAlgorithmsBenchmarkingDatabases, ProteinPhosphorylationProteomicsPhosphoproteinsProtein Kinases

Identifiers

PMID41160492
PMCPMC12579546

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.